Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 398 participants.
Also called NCT05199194
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 398 participants
- Registry
-
NCT05199194
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT05199194. Randomized; quadruple masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2026-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
- Acronym
- DIRECT-TNK
- Condition
- Stroke, Ischemic
- Condition
- Stroke, Acute
- Intervention (Drug)
- Tenecteplase
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hospital Moinhos de Vento
- Collaborator
- Ministry of Health, Brazil
- Collaborator
- Boehringer Ingelheim
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct05199194- Content hash
61611317ddd6b32fa2142f6232f8b8f684564a9c819309a873c691360498bdb2